LA-Bac8c

Send Inquiry
LA-Bac8c
Details
•Product Name: LA-Bac8c (Lipoic-Acid-Modified Bac8c Antimicrobial Peptide)
•Sequence: [5-(1,3-dithiolan-4-yl)pentanoyl]-Arg-Ile-Trp-Val-Ile-Trp-Arg-Arg-NH2
•Length: 8 residues (N-terminal lipoic acid fatty-acid ligand)
•Molecular Formula: C65H102N20O9S2
•Molecular Weight: 1371.76 Da
•Origin: N-terminal lipoic-acid conjugate of bovine cathelicidin Bac8c
•Purity: HPLC ≥95%
Related Docs: COA/MS/HPLC Report, Peptide Solubility and Storage Guide
Category
Antimicrobial Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of la-bac8c in China, also supports custom service. Welcome to wholesale bulk high quality la-bac8c from our factory. Contact us for more details.

 

Description LA-Bac8c is an engineered N-terminal lipoic-acid (LA) conjugate of the natural bovine cathelicidin Bac8c (RIWVIWRR-NH2), linked via LA's carboxyl to the Bac8c N-terminus. Molecular formula C65H102N20O9S2, MW 1371.76 Da. Using lipoic acid as a hydrophobic fatty-acid ligand markedly enhances antibacterial potency: MICs against S. aureus, MRSA, S. epidermidis, E. coli, and P. aeruginosa are 1, 4, 8, 8, and 8 ug/mL respectively, lower than unmodified Bac8c. LA-Bac8c combines lipoic acid antioxidant activity with Bac8c membrane-disrupting action, serving as a tool for fatty-acid-conjugated short-AMP design and antimicrobial biomaterials.
Structure type Lipidated 8-mer (lipoic acid-RIWVIWRR-NH2, C-amidated Trp/Arg-rich AMP)
Solubility Readily soluble in DMSO, water
Storage Powder -20C, dry, protected from light

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
LA-Bac8c Lipoic acid-modified Bac8c; LA-RIWVIWRR-NH2 Antimicrobial peptide, Synthetic short peptide, Lipopeptide, Lipoic acid-modified, C-terminal amidated, Anti-Gram-positive, Anti-Gram-negative, Anti-MRSA, Membrane-active 8-residue synthetic antimicrobial lipopeptide, an N-terminal lipoic acid (LA) conjugate of Bac8c derived from bovine neutrophil bactenecin; sequence LA-RIWVIWRR-NH2, where LA = 5-(1,3-dithiolan-4-yl)pentanoic acid (lipoic acid); C-terminally amidated; net charge +3 (3 Arg), Trp-containing hydrophobic residues; N-terminal lipidation enhances membrane affinity; contains a dithiolane (S-S) ring. C65H102N20O9S2 1370.94 1371.78 TFA salt (trifluoroacetate) 8

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-LABAC8C-01 White powder Store sealed, dry and protected from light at -20°C; light-sensitive due to Trp; avoid repeated freeze-thaw. Ship/place short-term at 2-8°C; aliquotted working solution ~1 month at -20°C. Moderate water solubility due to the N-terminal lipoic acid chain: first dissolve in a small volume of DMSO, then dilute with aqueous buffer to target concentration; protect from light due to Trp; do not keep solution at 4°C beyond 24 h. Solid powder dry, light-protected, long-term >2 years at -20°C; stable for short-term shipping at room temperature.

Functional Description

 

Product Code Frontend Short Summary Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-LABAC8C-01 Lipoic acid (LA)-modified 8-residue synthetic antimicrobial lipopeptide derived from bactenecin analog Bac8c, C-terminally amidated, with broad-spectrum activity against Gram-positive/Gram-negative bacteria including MRSA; membrane-targeted bactericidal. LA-Bac8c is a lipopeptide antimicrobial agent obtained by conjugating lipoic acid (LA) to the N-terminus of the synthetic 8-mer peptide Bac8c (sequence RIWVIWRR-NH2), itself a truncated optimized derivative of bovine neutrophil bactenecin/Bac2A. The appended lipoic acid greatly enhances membrane affinity and insertion, further improving antimicrobial potency over the parent Bac8c. LA-Bac8c potently inhibits S. aureus, methicillin-resistant S. aureus (MRSA), S. epidermidis, E. coli and P. aeruginosa, with MICs of 1, 4, 8, 8 and 8 μg/mL, respectively. Its bactericidal mechanism is predominantly membrane-targeted: the three Arg residues drive electrostatic attraction to negatively charged bacterial membrane components (lipoteichoic acid, LPS), while the lipoic acid lipid chain and Trp hydrophobic residues insert into the lipid bilayer, causing membrane depolarization, permeabilization and leakage of intracellular contents. The dithiolane ring of lipoic acid may also confer additional antioxidant activity. Antimicrobial peptide research, Anti-drug-resistant bacteria (MRSA), Lipopeptide design, Membrane-active mechanism, Anti-infective drug screening, Anti-biofilm Bacterial membrane (phosphatidylglycerol/LPS/lipoteichoic acid); lipoic acid dithiolane redox moiety

 

 

 

 

Hot Tags: la-bac8c, China la-bac8c manufacturers, suppliers, factory, 79404-91-4, 849352-44-9, CAS 143459 88 5, Combi-1, CP7-FP13-2, Elf18

Send Inquiry